2030: 60 Second Glioblastoma AI Robotic Surgery

In this platform, an on-premises repository-based large language model (LLM) simulation provides commands to standard oncology surgical robots based on real-time sensor data which are controlled via x, y, z coordinates to administer patient treatment while minimizing robot error. This was achieved through several Claude Code prompts for code instructions, code generation, and code execution. This thesis is positioned as an opportunistic extension of the U.S. Food and Drug Administration April 2026 Real-Time Clinical Trials announcement, now with the surgical theater where a hypothetical 2030 4-arm Medtronic robot closes a 5x-200x performance gap against the Medtronic ROSA ONE Brain v3.0 baseline on tip velocity (1,000 vs 50 mm/s), acceleration (10,000 vs 200 mm/s squared), E-stop latency (5 vs 50 ms), and force resolution (0.001 vs 0.01 N). A 54 x 1001 row sensor sample table, a 16-iteration deterministic sweep, and an on-premises LLM tournament were steps achieved to accelerate clinical trial robotic workflows. Practical real-life adoption still requires bridging the synthetic patient gap and adopting TRIPOD+AI plus CREMLS reporting floors.